RBCL IMO is setup for a multi-bag move. The had an excellent third quarter report with EPS of $0.04. That is great for a company that last traded at $0.50. IMO the stock is grossly undervalued. RBCL sells nutritional and medical products so they are in the right sector. They have been growing for the past several years and I expect that growth to continue. They also have a book value of $0.43/share including $7.1M in cash so they are in a stellar financial position.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.